Nimbus Synergies Leads Investment in MetaOptima to Accelerate FDA Approval and US Market Adoption of its AI-Powered Skin Diagnostics Platform

Nimbus Synergies, a leading Canadian early-stage health technology investor, has led a $2.6 million investment in MetaOptima Technology, a digital health company that is revolutionizing the dermatology and skin care industry with affordable, effective, and intelligent AI-driven solutions. Existing investors, including Skip Capital and AirTree Ventures, also contributed to the funding round.